SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001962918-23-000047
Filing Date
2023-12-20
Accepted
2023-12-20 16:38:48
Documents
12
Period of Report
2023-12-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K slrn-20231218.htm   iXBRL 8-K 26888
  Complete submission text file 0001962918-23-000047.txt   156098

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT slrn-20231218.xsd EX-101.SCH 1892
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT slrn-20231218_lab.xml EX-101.LAB 24833
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT slrn-20231218_pre.xml EX-101.PRE 13037
6 EXTRACTED XBRL INSTANCE DOCUMENT slrn-20231218_htm.xml XML 2815
Mailing Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301
Business Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301 805-871-4300
ACELYRIN, Inc. (Filer) CIK: 0001962918 (see all company filings)

IRS No.: 852406735 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41696 | Film No.: 231501775
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)